Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults: The VIDARIS randomized controlled trial

JAMA

Volumn 308, Issue 13, 2012, Pages 1333-1339

  Murdoch, David R ^a,b   Slow, Sandy ^a   Chambers, Stephen T ^a,c   Jennings, Lance C ^a,b   Stewart, Alistair W ^d   Priest, Patricia C ^e   Florkowski, Christopher M ^a,b   Livesey, John H ^b   Camargo, Carlos A ^f   Scragg, Robert ^d  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b CANTERBURY HEALTH LABORATORIES   (New Zealand)

^c CHRISTCHURCH HOSPITAL   (New Zealand)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

^e UNIVERSITY OF OTAGO   (New Zealand)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; PLACEBO; 25-HYDROXYVITAMIN D; COLECALCIFEROL; DRUG DERIVATIVE; VITAMIN; VITAMIN D;

ABSENTEEISM; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; HUMAN EXPERIMENT; INCIDENCE; MALE; NEW ZEALAND; NORMAL HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TREATMENT DURATION; UPPER RESPIRATORY TRACT INFECTION; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HOSPITALIZATION; MIDDLE AGED; ORAL DRUG ADMINISTRATION; RESPIRATORY TRACT INFECTION; RISK;

ABSENTEEISM; ADMINISTRATION, ORAL; ADULT; CHOLECALCIFEROL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RESPIRATORY TRACT INFECTIONS; RISK; SEVERITY OF ILLNESS INDEX; VITAMIN D; VITAMINS;

EID: 84866910452     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2012.12505     Document Type: Article

References (28)

1. 3 in infectious diseases. Crit Rev Microbiol. 2012;38(2):122-135.
2. Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2009;169(4):384-390.
3. Karatekin G, Kaya A, Salihoǧlu Ö, Balci H, Nuhoǧlu A. Association of subclinical vitamin D deficiency in newborns with acute lower respiratory infection and their mothers. Eur J Clin Nutr. 2009;63(4):473-477.
4. Laaksi I, Ruohola J-P, Tuohimaa P, et al. An association of serum vitamin D concentrations <40 nmol/L with acute respiratory tract infection in young Finnish men. Am J Clin Nutr. 2007;86(3):714-717. (Pubitemid 47435839)
5. Sattar N, Welsh P, Panarelli M, Forouhi NG. Increasing requests for vitamin D measurement: costly, confusing, and without credibility. Lancet. 2012;379(9811):95-96.
6. Avenell A, Cook JA, Maclennan GS, Macpherson GC. Vitamin D supplementation to prevent infections: a sub-study of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438). Age Ageing. 2007;36(5):574-577. (Pubitemid 47554950)
7. Laaksi I, Ruohola J-P, Mattila V, Auvinen A, Ylikomi T, Pihlajamäki H. Vitamin D supplementation for the prevention of acute respiratory tract infection: a randomized, double-blinded trial among young Finnish men. J Infect Dis. 2010;202(5):809-814.
8. 3 supplementation for the prevention of symptomatic upper respiratory tract infections. Epidemiol Infect. 2009;137(10):1396-1404.
9. Ilahi M, Armas LAG, Heaney RP. Pharmacokinetics of a single, large dose of cholecalciferol. Am J Clin Nutr. 2008;87(3):688-691. (Pubitemid 351364551)
10. 3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr. 2001;73(2):288-294.
11. Barrett B, Hayney MS, Muller D, et al. Meditation or exercise for preventing acute respiratory infection: a randomized controlled trial. Ann Fam Med. 2012;10(4):337-346.
12. Barrett B, Brown R, Mundt M. Comparison of anchor- based and distributional approaches in estimating important difference in common cold. Qual Life Res. 2008;17(1):75-85.
13. Barrett B, Brown R, Mundt M, et al. The Wisconsin Upper Respiratory Symptom Survey is responsive, reliable, and valid. J Clin Epidemiol. 2005;58(6):609-617. (Pubitemid 40692727)
14. Barrett B, Locken K, Maberry R, et al. The Wisconsin Upper Respiratory Symptom Survey (WURSS): a new research instrument for assessing the common cold. J Fam Pract. 2002;51(3):265.
15. Barrett B, Brown RL, Mundt MP, et al. Validation of a short form Wisconsin Upper Respiratory Symptom Survey (WURSS-21). Health Qual Life Outcomes. 2009;7:76.
16. Jennings LC, MacDiarmid RD, Miles JAR. A study of acute respiratory disease in the community of Port Chalmers, I: illnesses within a group of selected families and the relative incidence of respiratory pathogens in the whole community. J Hyg (Lond). 1978;81(1):49-66. (Pubitemid 8401665)
17. Monto AS, Sullivan KM. Acute respiratory illness in the community: frequency of illness and the agents involved. Epidemiol Infect. 1993;110(1):145-160. (Pubitemid 23217338)
18. Schafer JL. Analysis of Incomplete Multivariate Data. New York, NY: Chapman & Hall; 1997.
19. Camargo CA Jr, Ganmaa D, Frazier AL, et al. Randomized trial of vitamin D supplementation and risk of acute respiratory infection in Mongolia. Pediatrics. 2012;130(3):e561-e567.
20. Manaseki-Holland S, Maroof Z, Bruce J, et al. Effect on the incidence of pneumonia of vitamin D supplementation by quarterly bolus dose to infants in Kabul: a randomised controlled superiority trial. Lancet. 2012;379(9824):1419- 1427.
21. Lehouck A, Mathieu C, Carremans C, et al. High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med. 2012;156(2):105-114.
22. Urashima M, Segawa T, Okazaki M, KuriharaM, Wada Y, Ida H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr. 2010;91(5):1255-1260.
23. Sanders KM, Stuart AL, Williamson EJ, et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA. 2010;303(18):1815-1822.
24. Trivedi DP, Doll R, Khaw KT. Effect of 4 monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ. 2003;326(7387):469.
25. Martineau AR. Bolus-dose vitamin D and prevention of childhood pneumonia. Lancet. 2012;379 (9824):1373-1375.
26. Wilbur AK, Kubatko LS, Hurtado AM, Hill KR, Stone AC. Vitamin D receptor gene polymorphisms and susceptibility M tuberculosis in native Paraguayans. Tuberculosis (Edinb). 2007;87(4):329-337. (Pubitemid 46936238)
27. Martineau AR, Timms PM, Bothamley GH, et al. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet. 2011; 377(9761):242-250.
28. Committee to Review Dietary Reference Intakes for Vitamin D and Calcium. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academies Press; 2011.